Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells

Digestion

Volumn 79, Issue 4, 2009, Pages 215-219

  Nakamura, Fumiyasu ^a   Watanabe, Tomohiro ^a   Hori, Kimiko ^a   Ohara, Yoshiaki ^a   Yamashita, Kouhei ^a   Tsuji, Yoshihisa ^a   Ueda, Yoshihide ^a   Mikami, Sakae ^a   Nakase, Hiroshi ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bone marrow; Cytokine; Inflammatory bowel diseases; Myelodysplastic syndrome

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; TACROLIMUS;

ABDOMINAL PAIN; ADULT; APOPTOSIS; ARTICLE; BLOOD EXAMINATION; BONE MARROW CELL; BONE MARROW EXAMINATION; CASE REPORT; CELL STIMULATION; CHROMOSOME ABERRATION; COLONOSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE ASSOCIATION; ENDOSCOPY; ENTERITIS; FEVER; GENE EXPRESSION; HISTOLOGY; HOSPITAL MANAGEMENT; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MONOCYTE; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRISOMY 8; ULCERATIVE COLITIS;

BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 65449178870     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213486     Document Type: Article

References (15)

1. Strober W, Fuss I, Mannon P: The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-521.
2. Strober W, Murray PJ, Kitani A, Watanabe T: Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006;6:9-20.
3. Strober W, Fuss IJ, Blumberg RS: The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
4. James SP: Allogeneic bone marrow transplantation in Crohn's disease. Gastroenterology 1998;114:596-598.
5. Sloand EM, Wu CO, Greenberg P, Young N, Barrett J: Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. J Clin Oncol 2008;26:2505-2511.
6. Chen G, Zeng W, Miyazato A, Billings E, Maciejewski JP, Kajigaya S, Sloand EM, Young NS: Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 2004;104:4210-4218.
7. Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M: Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis: Behcet's syndrome. Leuk Lymphoma 2001;42:115-121.
8. Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Ogawa N, Hirose Y, Ozaki K, Shimanaka K, Takase S, Ueno H, Umehara H: Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med 2006;45:1309-1314.
9. Nonami A, Takenaka K, Sumida C, Aizawa K, Kamezaki K, Miyamoto T, Harada N, Nagafuji K, Teshima T, Harada M: Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behcet's disease by up-front cord blood transplantation. Intern Med 20 07;46:1753-1756.
10. Harewood GC, Loftus EV Jr, Tefferi A, Tremaine WJ, Sandborn WJ: Concurrent inflammatory bowel disease and myelodys-plastic syndromes. Inf lamm Bowel Dis 1999;5:98-103.
11. Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med 1999;341: 1284-1291.
12. Watanabe T, Asano N, Murray PJ, Ozato K, Tailor P, Fuss IJ, Kitani A, Strober W: Muramyl dipeptide activation of nucleotidebinding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 2008;118:545-559.
13. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, Strober W: Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006;25:473-485.
14. Watanabe T, Katsukura H, Shirai Y, Yamori M, Nishi T, Chiba T, Kita T, Wakatsuki Y: A liver tolerates a portal antigen by generating CD11c cells, which select Fas ligand Th2 cells via apoptosis. Hepatology 2003;38:403-412.
15. Yamamoto S, Nakase H, Mikami S, Inoue S, Yoshino T, Takeda Y, Kasahara K, Ueno S, Uz a N, K ita mur a H, Ta ma k i H, Mat suu r a M, Inui K, Chiba T: Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther 2008;28:589-597.